Induction of Transcriptional Gene Silencing by Expression of shRNA Directed to c-Myc P2 Promoter in Hepatocellular Carcinoma by Tissue-Specific Virosomal Delivery-Reference-Cited by-同舟云学术

Induction of Transcriptional Gene Silencing by Expression of shRNA Directed to c-Myc P2 Promoter in Hepatocellular Carcinoma by Tissue-Specific Virosomal Delivery

Published:2017 Issue: Volume: Page:245-257
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Zakaria Mohammad Khalid,Sarkar Debi P.,Chattopadhyay Parthaprasad

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-6716-2_14

Reference26 articles.

1. Ryder SD (2003) Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52(suppl 3):iii1–iii8

2. Khan I, Zakaria MK, Kumar M, Mani P, Chattopadhyay P, Sarkar DP et al (2015) A novel placental like alkaline phosphate promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting. J Transl Med 13:254

3. Zakaria MK, Khan I, Mani P, Chattopadhyay P, Sarkar DP, Sinha S (2014) Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells. BMC Cancer 14(1):582

4. Lin C-P, Liu J-D, Chow J-M, Liu C-R, Liu HE (2007) Small-molecule c-Myc inhibitor, 10058-F4, inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. Anticancer Drugs 18(2):161–170

5. Buyens K, De Smedt SC, Braeckmans K, Demeester J, Peeters L, van Grunsven LA et al (2012) Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. J Control Release 158(3):362–370

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation;Pathology - Research and Practice;2022-05

2. Breast Cancer Stem Cell Therapeutics, Multiple Strategies Versus Using Engineered Mesenchymal Stem Cells With Notch Inhibitory Properties: Possibilities and Perspectives;Journal of Cellular Biochemistry;2017-07-04